Etoposide | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Etoposide | hsa00340 | Histidine metabolism | 4.52E-02 | 1 | O95954 | FTCD | More | |
Etoposide | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | |
Etoposide | hsa00531 | Glycosaminoglycan degradation | 4.51E-02 | 2 | P22304, P06865 | IDS, HEXA | More | |
Etoposide | hsa00564 | Glycerophospholipid metabolism | 9.70E-03 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | |
Etoposide | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Etoposide | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | |
Etoposide | hsa01100 | Metabolic pathways | 2.25E-02 | 7 | Q9Y259, Q13956, P49619, O95954, Q02318, Q9UBX8, P35573 | CHKB, PDE6H, DGKG, FTCD, CYP27A1, B4GALT6, AGL | More | |
Etoposide | hsa03320 | PPAR signaling pathway | 1.62E-02 | 2 | Q13133, Q02318 | NR1H3, CYP27A1 | More | |
Etoposide | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | |
Etoposide | hsa04072 | Phospholipase D signaling pathway | 3.55E-02 | 4 | Q9UQC2, Q8WYR1, Q15438, P51828 | GAB2, PIK3R5, PSCD1, ADCY7 | More | |
Etoposide | hsa04110 | Cell cycle | 3.57E-02 | 3 | Q9UBD5, P06493, P33981 | ORC3, CDK1, TTK | More | |
Etoposide | hsa04142 | Lysosome | 3.32E-03 | 6 | P06865, P22304, Q13510, P07602, P61916, Q04900 | HEXA, IDS, ASAH1, PSAP, NPC2, CD164 | More | |
Etoposide | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | |
Etoposide | hsa04213 | Longevity regulating pathway - multiple species | 3.03E-02 | 2 | P51828, P0DMV8 | ADCY7, HSPA1A | More | |
Etoposide | hsa04261 | Adrenergic signaling in cardiomyocytes | 8.89E-03 | 5 | P67936, P51828, Q8WYR1, Q13362, P0DP24 | TPM4, ADCY7, PIK3R5, PPP2R5C, CALM2 | More | |
Etoposide | hsa04270 | Vascular smooth muscle contraction | 1.86E-02 | 4 | P0DP24, P51828, P35579, P35749 | CALM2, ADCY7, MYH9, MYH11 | More | |
Etoposide | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | |
Etoposide | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | |
Etoposide | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | |
Etoposide | hsa04915 | Estrogen signaling pathway | 1.12E-02 | 4 | P51828, P0DMV8, P0DP24, Q15788 | ADCY7, HSPA1A, CALM2, NCOA1 | More | |
Etoposide | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | |
Etoposide | hsa04921 | Oxytocin signaling pathway | 2.92E-02 | 4 | P0DP24, P51828, Q96RR4, Q8WYR1 | CALM2, ADCY7, CAMKK2, PIK3R5 | More | |
Etoposide | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
Etoposide | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | |
Etoposide | hsa05145 | Toxoplasmosis | 3.55E-02 | 3 | P23458, Q8WYR1, P0DMV8 | JAK1, PIK3R5, HSPA1A | More | |
Etoposide | hsa05231 | Choline metabolism in cancer | 2.00E-02 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | |